G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $177,908 | +16.5% | 23,409 | +56.5% | 0.00% | 0.0% |
Q4 2021 | $152,731 | +14.5% | 14,959 | +50.5% | 0.00% | 0.0% |
Q3 2021 | $133,395 | -61.3% | 9,940 | -36.7% | 0.00% | -66.7% |
Q2 2021 | $344,326 | -8.8% | 15,694 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $377,598 | +33.7% | 15,694 | 0.0% | 0.00% | +33.3% |
Q4 2020 | $282,335 | +55.8% | 15,694 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $181,266 | -52.4% | 15,694 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $380,736 | +120.1% | 15,694 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $172,948 | -58.3% | 15,694 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $414,792 | +16.0% | 15,694 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $357,509 | -25.7% | 15,694 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $481,174 | +200.2% | 15,694 | +62.5% | 0.01% | +150.0% |
Q1 2019 | $160,273 | -13.3% | 9,655 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $184,893 | -63.4% | 9,655 | 0.0% | 0.00% | -60.0% |
Q3 2018 | $504,860 | +20.2% | 9,655 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $420,000 | +73.6% | 9,655 | +47.8% | 0.01% | +66.7% |
Q1 2018 | $242,000 | – | 6,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |